Two vitamin C manufacturers based in China are reportedly arguing in a New York court that their government is responsible for their price-fixing. A class-action suit has been filed in US District Court in New York accusing two vitamin C companies of raising prices between December 2001 and June 2006. The media are reporting that the defendants will use the foreign sovereign compulsion doctrine defense, a rare argument that claims companies that break US law are protected if their own governments coerced the companies into that legal violation. The defense is seldom successful, say experts. Jury selection was scheduled for Monday.
Featured News
Senate Committee Advances Quantum Computing Bill
Apr 15, 2026 by
CPI
EU Tightens Grip on Big Tech with New Age Verification App
Apr 15, 2026 by
CPI
EU Moves to Force Meta to Restore Rival AI Access on WhatsApp
Apr 15, 2026 by
CPI
South Korea Nears Conclusion of Gas Station Collusion Probe Amid Rising Oil Prices
Apr 15, 2026 by
CPI
Westlake Agrees to $67 Million Settlement in US PVC Pipe Antitrust Case
Apr 15, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Competitor Collaborations
Mar 26, 2026 by
CPI
Between Scylla and Charybdis – Navigating Transatlantic Antitrust Currents
Mar 26, 2026 by
Tilman Kuhn & Niklas Brüggemann
Cartel Enforcement Moves Into the Labor Market: Trends and Implications
Mar 26, 2026 by
Andreas Kafetzopoulos & Caroline Janssens
Rethinking Buy-Side Antitrust “Group Boycotts”
Mar 26, 2026 by
Craig Falls & Brendan McGuire
Positive Collaborations: The Tools Available to Competition Authorities to Encourage Beneficial Interactions Between Competitors
Mar 26, 2026 by
Rona Bar-Isaac & Thomas Withers